DeepView® System highlighted at the European Burns Association Congress

DALLAS, Sept. 10, 2025 (GLOBE NEWSWIRE) --Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced its prominent role at the European Burns Association (EBA) conference, held from September 3rd – 6th in Berlin, Germany. The Company was featured in multiple presentations, highlighting its contributions to advancing burn care across the globe.

Mr. Chris Lewis, Consultant Burn and Plastic Surgeon from Royal Victory Infirmary in Newcastle, said “With multiple presentations and posters from my team, colleagues and fellow users of DeepView in the United Kingdom, I was excited to see the results of their research and the interest by the European Burn Specialists. Our institution, as an early adopter, continues to use and see the value of the DeepView technology and we look forward to continuing to develop research and share our findings.”

The European Burns Association Congress is a non-profit forum uniting specialists, researchers, and allied professionals to share knowledge, advance research, and promote best practices in burn prevention and treatment across Europe.

Dr. J. Michael DiMaio, Chairman of the Board of Spectral AI, expressed pride in the Company’s role at the conference: “I am pleased with the DeepView System’s reception and results from our initial placement in the United Kingdom. We continue to seek physician feedback and support to bring this advanced burn wound technology to the worldwide market.”

Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns. The Company is working to revolutionize the management of wound care by “Seeing the Unknown®” with its DeepView System. The DeepView System is being developed as a predictive device to offer clinicians an objective and immediate assessment of a burn wound’s healing potential prior to treatment or other medical intervention. With algorithm-driven results and a goal of exceeding the current standard of care in the future, the DeepView System is expected to provide fast and accurate treatment insight towards value care by improving patient outcomes and reducing healthcare costs. For more information about the DeepView System, visitwww.spectral-ai.com.

Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s strategy, plans, objectives, initiatives and financial outlook. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. As such, readers are cautioned not to place undue reliance on any forward-looking statements.

Investors should carefully consider the foregoing factors, and the other risks and uncertainties described in the “Risk Factors” sections of the Company’s filings with the SEC, including the Registration Statement and the other documents filed by the Company. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements.

David KugelmanAtlanta Capital Partners LLC(866) 692-6847 Toll Free - U.S. & Canada(404) 281-8556 Mobile and WhatsAppEmail:dk@atlcp.com